Latest News

Find updates from Cogstate, leaders in the measurement of cognition.

Cogstate Further Bolsters Alzheimer’s Disease Expertise, Welcoming Dr. Annamarie Vogt as Associate Vice President, AD Study Design and Endpoint Quality
November 6, 2024

Cogstate Further Bolsters Alzheimer’s Disease Expertise, Welcoming Dr. Annamarie Vogt as Associate Vice President, AD Study Design and Endpoint Quality

Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with eCOA and Clinician Solutions Powered by AI and Advanced Analytics
October 29, 2024

Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with eCOA and Clinician Solutions Powered by AI and Advanced Analytics

Cogstate Expands Alzheimer’s Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
October 14, 2024

Cogstate Expands Alzheimer’s Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer

Cogstate Announces Scientific Leadership Updates
January 30, 2024

Cogstate Announces Scientific Leadership Updates

Cogstate Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Measures for Alzheimer’s Disease
June 20, 2022

Cogstate Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Measures for Alzheimer’s Disease

Cogstate Announces Formation of Scientific Advisory Board
June 14, 2022

Cogstate Announces Formation of Scientific Advisory Board

Clario and Cogstate Expand Partnership to Deliver Leading Data Collection and Data Quality Programs for Clinical Trials
May 20, 2022

Clario and Cogstate Expand Partnership to Deliver Leading Data Collection and Data Quality Programs for Clinical Trials

Eisai to Launch Digital Tool “CogMate™ in Taiwan And Hong Kong
January 12, 2022

Eisai to Launch Digital Tool “CogMate™ in Taiwan And Hong Kong

Cogstate Technology to be Installed on Japanese Smartphone Targeting Senior Population
November 30, 2021

Cogstate Technology to be Installed on Japanese Smartphone Targeting Senior Population

Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod
November 29, 2021

Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod

Cogstate
© 2025 Cogstate Ltd.

Cogstate acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the lands where many of our team members live and work. We pay respect to their Elders past and present.